基于纤维蛋白凝胶的局部策略用于术后癌症的同步放化疗
研究开发了载顺铂的纤维蛋白凝胶平台,植入术后瘤床并联合放疗,用于预防术后局部复发和远处转移。在小鼠术后皮下肿瘤模型中,该平台可局部持续释放顺铂,增强放疗对残留肿瘤的疗效并降低全身毒性,在乳腺癌、未分化甲状腺癌和骨肉瘤模型中均显示治疗获益。
要点
- 载顺铂纤维蛋白凝胶植入术后瘤床可局部持续释放顺铂。
- 该策略增强放疗对残留肿瘤的疗效并降低全身毒性。
- 在乳腺癌、未分化甲状腺癌和骨肉瘤小鼠模型中显示治疗获益。
核心结论
- 研究提供了一种用于同步放化疗的通用平台,以预防术后癌症复发和转移。
研究设计与样本
- 研究开发了载顺铂的纤维蛋白凝胶平台,植入术后瘤床并联合同步放疗。
- 采用原发肿瘤不完全切除建立的术后皮下肿瘤小鼠模型评价该同步放化疗方案的疗效。
主要发现
- 纤维蛋白凝胶中顺铂的局部持续释放可增强放疗对残留肿瘤的抗肿瘤疗效,并降低全身毒性。
- 该方法的治疗获益在乳腺癌、未分化甲状腺癌和骨肉瘤小鼠模型中得到展示。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Postoperative cancer recurrence and metastasis have always been huge challenges in cancer therapy. The concurrent cisplatin (CDDP)-based chemoradiotherapy regimen is a standard therapeutic strategy in some cancer treatments after surgical resection. However, severe side effects and unsatisfactory local tumor concentrations of CDDP have hampered the application of this concurrent chemoradiotherapy. Therefore, a superior option that can enhance CDDP-based chemoradiotherapy efficacy with milder concurrent therapy-related toxicity is highly desirable. METHODS AND MATERIALS: We developed a platform based on fibrin gel (Fgel) loaded with CDDP to be implanted into the tumor bed after surgery combined with concurrent radiation therapy for the prevention of postoperative local cancer recurrence and distant metastasis. The postoperative subcutaneous tumor mouse models established by incomplete resection of primary tumors were used to evaluate the therapeutic advantages of this chemoradiotherapy regimen for postsurgical treatment. RESULTS: The local and sustained release of CDDP from Fgel could enhance the antitumor efficacy of radiation therapy in the residual tumor with lower systemic toxicity. The therapeutic benefits of this approach are demonstrated in breast cancer, anaplastic thyroid carcinoma, and osteosarcoma mouse models. CONCLUSIONS: Our work offers a general platform for concurrent chemoradiotherapy to prevent postoperative cancer recurrence and metastasis.
引用
- Yang X, Zheng L, Gao L, et al. A Local Strategy Toward Concurrent Chemoradiotherapy Based on Fibrin Gel for Postsurgical Cancer Treatment. Int J Radiat Oncol Biol Phys. 2023. PMID: 36796499. doi:10.1016/j.ijrobp.2023.02.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。